Skip to main contentBack to Top

Pathology sits at the cusp of basic and clinical sciences. This unique position allows the Medical College of Georgia Department of Pathology to contribute in an important and meaningful manner to clinical care through the provision of timely and accurate diagnoses as well as laboratory testing results. At the same time, investigative approaches within the department seek to further define our understanding of disease processes, paving the way for therapeutic interventions.

The Department embraces the tripartite mission of the Medical College of Georgia i.e. clinical service, education, and research. The Department of Pathology (Anatomic and Clinical Pathology) has 22 clinical faculty, including 2 members based at the Athens Campus, and 6 research faculty. Clinical services are delivered primarily to AU Medical Center's 478 bed adult hospital and the 154 bed Children’s Hospital of Georgia.

The Department also operates Georgia Esoteric Molecular Laboratory, an independently licensed and CLIA certified reference laboratory, which provides esoteric molecular testing and pathology consultation services for hospitals and physicians. Approximately 1.3 million clinical laboratory procedures and 13,500 surgical specimens are processed annually. With specialty trained experts in almost every area of anatomic and clinical pathology, we provide diagnostic and consultative services, facilitating key clinical decisions.

As academic faculty, we shoulder the responsibility to provide a learning experience for students and residents that will catapult them into the professional arena as well-trained, knowledgeable, inquiring medical graduates and competent, compassionate, intellectually mature physicians. The Department plays a key role in the education of medical students with maximal interactions during the Phase 2. No longer a ‘stand alone’ course, instruction in Pathology is fully integrated as part of the Cellular and Systems Disease States in concert with medical microbiology and pharmacology. The Department also offers a number of electives for 3rd and 4th year students. The Graduate Medical Education program includes 12 residents and 2 fellows. Trainees participate in all activities within the Department, obtaining requisite competencies through graduated responsibilities as they progress towards their career goal of becoming competent diagnosticians and independent pathologists, whether in an academic or community practice.
The Department of Pathology’s faculty received approximately $10 million in NIH funding primarily through investigators in Augusta University's Center for Biotechnology and Genomic Medicine (CBGM) and the Cancer Center. These and other faculty, who maintain primary academic appointments within the Department of Pathology, substantially enhance the department’s research endeavor. Our clinical faculty are also engaged in correlative and translational research, providing opportunities for medical student and residents. Additionally the Department also serves as a central repository for a statewide network, the BioRepository Alliance of Georgia for Oncology (BRAG-Onc). BRAG-Onc currently consists of eleven contributing institutions in Georgia, with MCG as its leading and coordinating hub.

The Department of Pathology at Medical College of Georgia, Augusta University thus plays a key role in education and research while providing vital diagnostic and clinical consultative services throughout the state. I invite you to explore other areas of this website, or come and visit us to get a firsthand look at our department and meet with our faculty, staff, and trainees.


Relevant News


Dr. Han-Feng Ding gets 2.1 Million NIH grant.



Pathology Research Services

The Georgia Esoteric and Molecular laboratory has established the Pathology Research Services that prepares and stains animal and human tissue for your basic and clinical research.


Contact Us

Department of Pathology

Health Sciences Campus

Murphey Building



1120 15th Street, BF 104, Augusta, GA 30912

Pathology News

Two men with dark hair and wearing glasses and white coats stand side by side in lab

Nasal microbiota holds clues to who will develop symptoms from novel coronavirus

The microbiota in the nose and upper throat likely contains biomarkers for assessing how sick an individual infected with SARS-CoV-2 may get and for developing new treatment strategies to improve their outcome, researchers say.

Doctor in office

Patients with multiple myeloma with the shortest survival have the most kidney damage

Nearly 20% of patients with multiple myeloma have a form in which they make extreme quantities of one component of the abnormal antibody they are producing, and these so-called “free monoclonal light chains” pile up and damage the kidneys, investigators say.

Dr. Ravindra Kolhe stands in the forefront of a lab with his research associate looking on

High expression of cell death genes associated with early death from lung cancer

Patients with a high number of genes most associated with pathways that lead to cell death in lung cancer are at increased risk of dying early from their disease, researchers report.

two doctors

Larger panel finds more gene mutations, treatment targets for leukemia

Identifying more genetic mutations in an individual’s cancer enables more targeted treatment for patients. That includes finding mutations not previously associated with their cancer type, which opens the door to using drugs targeting those mutations that have traditionally been used against other cancers.